v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities    
Net loss for the period $ (12,514) $ (16,343)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of property and equipment 23 24
Share-based compensation expense (note 5) 1,368 981
Changes in operating assets and liabilities:    
Other receivables (54) (1)
Research and development tax credits receivable (91) (106)
Prepaid expenses (864) 280
Operating lease right of use asset, net 12 (87)
Accounts payable and accrued liabilities (350) (2,827)
Net cash used in operating activities (12,470) (18,079)
Investing Activities    
Maturity of short-term investments 12,000  
Net cash used in investing activities 12,000  
Financing activities    
Issuance of common shares on exercise of share options (note 5) 19 77
Net cash provided by financing activities 19 77
Net (decrease) in cash and cash equivalents during the period (451) (18,002)
Cash and cash equivalents – Beginning of period 72,310 119,818
Cash and cash equivalents – End of period $ 71,859 $ 101,816